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STUDY PROTOCOL Open Access
Study protocol of coaching end-of-life
palliative care for advanced heart failure
patients and their family caregivers in rural
appalachia: a randomized controlled trial
Ubolrat Piamjariyakul1*, Trisha Petitte1, Angel Smothers1, Sijin Wen2, Elizabeth Morrissey1, Stephanie Young1,
George Sokos3, Alvin H. Moss4 and Carol E. Smith5
Abstract
Background: Heart failure (HF) afflicts 6.5 million Americans with devastating consequences to patients and their
family caregivers. Families are rarely prepared for worsening HF and are not informed about end-of-life and
palliative care (EOLPC) conservative comfort options especially during the end stage. West Virginia (WV) has the
highest rate of HF deaths in the U.S. where 14% of the population over 65 years have HF. Thus, there is a need to
investigate a new family EOLPC intervention (FamPALcare), where nurses coach family-managed advanced HF care
at home.
Methods: This study uses a randomized controlled trial (RCT) design stratified by gender to determine any
differences in the FamPALcare HF patients and their family caregiver outcomes versus standard care group
outcomes (N = 72). Aim 1 is to test the FamPALcare nursing care intervention with patients and family members
managing home supportive EOLPC for advanced HF. Aim 2 is to assess implementation of the FamPALcare
intervention and research procedures for subsequent clinical trials. Intervention group will receive routine standard
care, plus 5-weekly FamPALcare intervention delivered by community-based nurses. The intervention sessions
involve coaching patients and family caregivers in advanced HF home care and supporting EOLPC discussions
based on patients’ preferences. Data are collected at baseline, 3, and 6 months. Recruitment is from sites affiliated
with a large regional hospital in WV and community centers across the state.
Discussion: The outcomes of this clinical trial will result in new knowledge on coaching techniques for EOLPC and
approaches to palliative and end-of-life rural home care. The HF population in WV will benefit from a reduction in
suffering from the most common advanced HF symptoms, selecting their preferred EOLPC care options, determining
their advance directives, and increasing skills and resources for advanced HF home care. The study will provide a long-
term collaboration with rural community leaders, and collection of data on the implementation and research procedures
for a subsequent large multi-site clinical trial of the FamPALcare intervention. Multidisciplinary students have opportunity
to engage in the research process.
Trial registration: ClinicalTrials.gov NCT04153890, Registered on 4 November 2019
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Background
Heart failure (HF) afflicts 6.5 million Americans [1] with
devastating consequences to patients and their family
caregivers, [2] especially during severe symptoms in the
end stage. Advanced HF was defined by American Heart
Association (AHA) as “the presence of progressive and/
or persistent severe signs and symptoms of HF despite
optimized medical, surgical, and device therapy [3].”
When patients and family members are not prepared for
worsening HF and are not informed about end-of-life
and palliative care (EOLPC) conservative comfort op-
tions, they experience depression, fear of painful death,
home care burden, and medical expenses from anxiously
seeking aggressive but futile care [4]. Notably, West
Virginia (WV) has the highest rate of HF deaths in the
U.S. at 32.6 per 100,000 population, [5] where 14% of
those are over 65 years have HF. WV is in the Appalachian
mountainous region, a high priority for research as resi-
dents experience extreme health and poverty inequities
and limited access to healthcare [6]. Furthermore, home
EOLPC is lacking across this disadvantaged rural area [7].
Thus, there is a need to investigate a new family interven-
tion (FamPALcare), where the nurses coach family-
managed advanced HF care at home.
Palliative care is a team-approach, patient-centered
comprehensive treatment of the discomfort, symptoms,
and stress of serious illness with the goals of preventing
and relieving suffering, and of improving quality of life
for patients and their families through early identifica-
tion, correct assessment, and treatment of pain and
other problems, whether physical, psychological, and/or
spiritual [8, 9]. WVU Center for Palliative Care adds that
palliative care should be provided regardless of patient’s
stage of disease or the need for other therapies, in ac-
cordance with patient’s values and preferences [10].
This study addresses the National Institutes of Health
Academic Research Enhancement Award (AREA) prior-
ities for conducting a low risk clinical trial to provide a
foundation to advance scientific EOLPC knowledge and
testing of our intervention efficacy in a larger clinical
trial. Additionally, effective EOLPC interventions are pri-
orities of palliative care professionals and palliative care
needs must be addressed with vulnerable and advanced
HF patients and their families [11, 12]. This study also
addresses the priority problem of the lack information
for families providing advanced HF home care and pre-
venting unwanted and unwarranted rehospitalizations at
the advanced stage of HF.
In FamPALcare intervention being used in this study,
nurses coach by information sharing and guiding patient
and family members to gain knowledge to manage the
frequent distressful advanced HF decline symptoms
(breathlessness, anxiety, depression, fatigue). Innovation
of the study includes gaining data about the knowledge,
and limited resources available for rural EOL care. The
FamPALcare materials were designed for low literacy,
which is a major barrier to serious illness care and is as-
sociated with poor health outcomes [13].
An important innovation of this intervention is the
component addressing family caregivers’ needs. A sys-
tematic review [14] showed a growing number of studies
verifying caregiver contributions to HF home care. How-
ever, all these studies are at an early stage of scientific
research. Thus, the FamPALcare intervention provides
family caregivers with the knowledge and practical skills
to monitor both the patient’s advancing HF status and
their own depression and home care burden [15, 16].
Through coaching, family caregivers can develop greater
confidence in providing HF home EOLPC and ensure
that the intervention reflects the patients’ and families’
preferences [17].
Overall, previous testing in these studies demonstrated
that a coaching approach was feasible, [15] provided HF
patients and caregivers with practical skills to partner
with professionals on EOLPC, increased home manage-
ment of patients’ breathlessness symptoms, [18] and re-
duced family caregiver burden and out-of-pocket costs
due to fewer rehospitalizations [19]. In this study, all
previously tested components are combined into our
novel FamPALcare intervention with significant ap-
proaches for rural families residing in Appalachia.
Conceptual model
Coaching Model for End-of-Life and Palliative Care Re-
search was used to guide selection of coaching compo-
nents, procedures, and measures targeted to accomplish
the study aims [20, 21]. This model depicts relationships
among clinical, psychological, and economic factors
affecting home EOLPC care. This model guides nurses
to coach family discussions of advance directives and
conservative management of HF home EOLPC options.
It measures HF status and family caregivers’ burden and
provides resources needed for HF care.
Methods/design
Aims
The overall objective is to test whether the 5-weekly
coaching FamPALcare intervention educational and sup-
portive sessions will improve rural home EOLPC for ad-
vanced HF at the 6 month follow up. Specific aims,
hypotheses, and objectives are listed in Table 1.
Design/methodology
This study uses a randomized controlled trial (RCT) de-
sign stratified by gender [22] to determine any differ-
ences in the FamPALcare HF patients and their family
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caregiver outcomes versus standard care group out-
comes (N = 72) (Table 2).
Randomization
Our statistician consultant will use computer-
generated random numbers for subject enrollment.
To ensure a balance design with gender, two equal
randomization lists will be used one for male and
one for female. Within each gender group the fam-
ilies will be randomly assigned into either control or
intervention groups in a 1:1 fashion. The group assign-
ment will be placed in the sealed envelope under each
gender group. Our RCT design is consistent with the
CONSORT standards, [23] and rigorous research proce-
dures. Recruiters will be blinded to group assignment until
informed consents are signed and after a group random
allocation of each patient/caregiver dyad [24, 25]. The pro-
posed design addresses threats to both internal and
external validity and is robust for detecting differences be-
tween small groups [26].
Characteristics of participants
The sample includes adult (≥18 years) advanced HF pa-
tients (NYHA III and IV and Stages C and D) [3] and
their family caregivers who are involved in daily home
care will be recruited. Both patients and caregivers will
provide consent, and will be randomly assigned to a
study group as a dyad.
Eligibility criteria
Inclusion criteria are dyads of family caregivers and pa-
tients with advanced systolic and diastolic HF. All partic-
ipants must be alert and oriented, provide written
consent, and be able to read and write in English. Family
caregivers are those designated by the HF patient as
non-paid primary persons who assists with HF home
care, thus not requiring the dyad to be spouses. Exclu-
sion criteria are patients who already received or are on
a waiting list for a heart transplant or left ventricular as-
sist device (LVAD); and those with other terminal illness
or dementia, such as Alzheimer’s disease. Also excluded
are those caregivers with a disability that precludes their
use of FamPALcare intervention materials such as those
suffering with Alzheimer’s disease.
Sample size
There will be 18 patient-caregiver dyads per each group
(total N = 72; 36 patients and 36 caregivers). Sample size
is based on calculated breathlessness, [18] the main pa-
tient outcome measured, and the HF patients’ and their
family caregivers’ greatest concern [27, 28]. This sample
size will have at least 80% power to detect a reduction of
one SD using one-sided two-sample t-test at a signifi-
cance level of 0.05. Further, a cardiologist, pulmonolo-
gist, and two palliative physicians experienced in caring
for patients with EOL breathlessness agreed that even a
0.5 standard deviation (SD) improvement is an indica-
tion of best possible management of advanced HF
breathlessness [29]. This sample size is also accounted
for an expected 20% attrition (due to HF deaths).
Table 1 List of Specific Aims, Hypotheses, and Objectives for
the Study
Specific Aim 1: Test the FamPALcare nursing care intervention with
patients and family members managing home supportive EOLPC for
advanced HF in rural WV.
Hypothesis 1a. The intervention group HF patients will rate greater
improvement on: (a) confidence and preparedness in management of
their severe HF (status, breathlessness, anxiety, and depression); (b)
increased numbers of signed decisions about their preferred EOLPC
options for advanced HF; (c) increased numbers of signed advance
directives, compared to control group patients at 6 months.
Hypothesis 1b. The intervention group family caregivers will rate greater
improvement on: (a) quality of life (physical, mental), (b) confidence and
preparedness in providing home HF EOLPC, and (c) home care burden,
compared to control group caregivers at 6 months.
Specific Aim 2: Assess implementation of the FamPALcare intervention
and research procedures for subsequent clinical trials.
Aim 2a. Evaluate the quality of EOLPC of the FamPALcare intervention
measured via (1) patient/family caregiver intervention helpfulness
questionnaire responses; (2) multidisciplinary healthcare professionals’
and rural community leaders’ focus group research on the FamPALcare
outcomes; and (3) determination of FamPALcare implementation cost
using traditional tabulated cost minimization analysis.
Aim 2b. Collect participant recruitment, enrollment, and retention rates
to determine future recruitment strategies and understand reasons for
non-participation to maintain good rates in rural clinical studies. The
fidelity of the FamPALcare intervention will be assessed using trained
research nurse observer checklists.
Table 2 FamPALcare Coaching Intervention (X1-X7) Sequence with Data Collection (O1-O3)
Random Group Assignment FamPALcare Intervention and Standard Care Groups Follow-up Data Collection Post-Intervention












Group 2 Standard Care O1 Standard care O2 O3
Note. O1-O3 = observation, data collection time points; X1–X5 = FamPALcare coaching intervention of weekly home visits. Nurse-administered and conducted
across 5 weeks, X6 = Booster Reinforcement at 3 months and reinforcement on each family selected conservative EOLPC options for patients and family members.
X7 = Evaluation of FamPALcare
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Settings, recruitment and retention plans
Successful strategies for recruiting research participants
in rural Appalachia will be used [30]. Recruitment is
from sites affiliated with a large regional hospital in WV
including Heart and Vascular Institute, local health cen-
ters or clinics, churches, physician offices and community
centers throughout the state. The cardiology nurse study
coordinator will identify potential participants prospect-
ively through daily reviews of hospital and outpatient re-
cords for all HF patient hospitalizations and clinic visits.
Personnel who already have clinic responsibilities and ac-
cess to patient records, consistent with HIPAA require-
ments, will perform subject eligibility screening and the
initial recruitment contact. Nurse researchers who are ac-
tive in our rural communities, will engage these commu-
nities in recruitment. There will be an expected delay in
enrollment during winter (December to March) due to ex-
treme weather and road conditions in rural Appalachia.
Our study coordinator will oversee participant timelines,
monitor, and report the progress of enrollment on quar-
terly basis.
All procedures outlined in retention strategies were
successful in prior longitudinal clinical trial studies [31].
Retention has been related to study recruitment being
performed by persons with similar characteristics to
those recruited. Having Appalachian community or
faith-based nurses for intervention implementation will
promote the engagement in the coaching sessions. To
enhance the retention rate, these research nurses will




The standard care group will receive routine HF instruc-
tion during hospital or clinic visits. All patients can be
referred for palliative care consults with an individual
from the WVU palliative care team if requested (all con-
sults will be tabulated). All patients in this study will
have standard HF care available through the WVU hos-
pital and outpatient clinics, prescribed by the patient’s
cardiologist. Standard HF care includes materials rou-
tinely given to all patients with HF at the hospital or
outpatient clinics.
FamPALcare intervention group
The FamPALcare intervention group will receive stand-
ard care, plus FamPALcare intervention delivered by
community-based nurses. FamPALcare intervention
involves coaching patients and family caregivers in ad-
vanced HF home care and supporting EOLPC discus-
sions. FamPALcare intervention will begin by using
recent American Heart Association (AHA) study recom-
mendations and the “Conversation Ready” for wording
when approaching the topic of EOL care [32] as a guide
along with an illustrated advanced HF trajectory graph
[20]. The nurse will coach the patient and family in
making decisions about EOLPC options based on their
preferences. Nurses will go over advance directive forms
and recommend that forms be signed and taken to their
next doctor appointment. Intervention participants will
receive five coaching sessions with telephone follow-up
to reinforce HF home care.
Our intervention nurses reinforce following the pre-
scribed medication and diet, timely symptom reporting,
family caregivers accepting help from others, sharing
emotions with trusted others, and taking short naps to
support their own health [33]. Referrals to local support
programs (i.e. church minister, volunteers, or faith-based
nurses) are made with the dyad’s permission. Applica-
tions for low-cost prescription drug programs will be
provided upon request. The number of referrals who
were contacted will be tracked to identify local resources
used. Because involvement of multiple family caregivers
is a common strength among Appalachians, secondary
family caregivers involved in home HF care will be
allowed to attend the intervention session. We will keep
track of how many have secondary family caregivers
participate.
During the sessions, the nurse will use the “teach-
back” process (“please describe what you learned today”)
to verify understanding at the end of each FamPALcare
discussion [15]. Then the nurse interventionist will tabu-
late and report on content needing reinforcement. A fol-
low up telephone calls will be conducted at 3 months to
reinforce the practice of FamPALcare.
Treatment fidelity and quality assurance procedures
Fidelity will be monitored by the PI using a fidelity rat-
ing scale. Fidelity rating is performed by observation
during the intervention to ensure the reliable and valid
implementation of the FamPALcare intervention [34].
For quality assurance measures, training sessions on
appropriate communication techniques and following
research protocols will be provided to the nurse inter-
ventionists and data collectors.
Data collection
Data will be collected from all patients and caregivers at
baseline, 3 months, and 6 months. The nurse will obtain
data from patients and caregivers separately, emphasizing
privacy and importance of each subjects’ independent an-
swers [24]. None of the intervention or data collection
nurses will be the HF patients’ usual healthcare providers.
To preclude diffusion of treatment across groups, the re-
search nurses working with the intervention group will be
different from nurses with the control group.
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Data management and quality assurance
Quality assurance and data integrity techniques include
data management protocols and an audit trail of the data
management decisions. Other data integrity techniques
include developing guides for verification of data, coding
each subject’s data, analyzing for data distributional fea-
tures of group equivalencies at baseline and meeting
statistical assumptions prior to quantitative analyses, and
the need for transformations [35]. Differences in age,
gender, or demographics between participants and those
who do not choose to participate will be reported.
Reasons for refusal to participate are recorded. Rules for
managing missing data will be discussed with our bio-
statistician consultants to examine missing at random or
repeated missing data and will be reported in publica-
tions. Missing data will be identified and recollected
within 2 weeks upon data check-in. Research staff will
use a REDCap survey to complete all data entry. Param-
eters to identify ranges and options for “decline to an-
swer” will be used to prevent and monitor invalid or
missing data. Data conversion from REDCap to SPSS/
SAS will be conducted on a weekly basis. The CON-
SORT enrollment diagram will be updated quarterly and
reported in our research team and Safety Monitoring
Committee (SMC) meetings.
Statistical analyses
The consulting biostatistician will guide the use of
intent-to-treat statistical approaches for all patient and
caregiver outcomes. All participants will complete demo-
graphic data at baseline. All instrument measures have
established discriminant or construct validity, internal
consistency, reliability, and specificity. Each has been
used with diverse populations, chronic illness patients,
and with HF families. The measures distinguish clinically
significant differences and are sensitive to change over
time [36]. As pretested, these questionnaires were easily
completed within 15–20min.
Data analysis for specific aim 1: hypothesis 1a & 1b
Table 3 illustrated the measures and instrument for
addressing Specific Aim 1, hypotheses 1a and 1 b.
Hierarchical linear models will be used to compare
groups in the presence of repeated measures and nested
family members. Models will include the fixed effects of
treatment, time, and the treatment-time interaction, with
patient and family caregiver effects treated as random to
account for the dependence among repeated observa-
tions on the same subject and among observations on
subjects within the same family, respectively. Models will
identify any changes in the outcome variables over time,
for differences in outcomes between the groups, and for
any within-group differences over time [46]. The SAS
Proc MIXED procedure will be used. General linear
hypothesis tests will be used to test for significant differ-
ences using linear contrasts of selected model parame-
ters. Point estimates and confidence intervals will also
be generated using contrasts and estimates of the appro-
priate linear combinations of model parameters. For
multiple testing, the overall experimental error rate will
be conserved by correcting the per-test error rate using
the Bonferroni procedure. Caregivers’ daily involvement,
as measured by burden scale, will be used as a potential
covariate. The numbers of mental health referral (for
Table 3 Measures and Instrument for Specific Aim 1 (Data collection at baseline, 3, and 6 months)
Measures: Specific Aim 1, Hypothesis 1a, 1b Operationally Defined
1a. Patient’s Kansas City Cardiomyopathy Questionnaire (KCCQ) [37]
12-item Likert.a, c, d, e [completed by patient]
Management of HF status, HF-related symptoms (i.e. breathlessness)
and physical function status, α = 0.90.a
1a. Tabulate proportion of patients selecting HF EOLPC options and
signing advance directives, and.
Identify preferred HF conservative care options.
Signed directives and confirmed EOLPC options
1a.1b Patient Health Questionnaire (PHQ-4) Scale, [38] 4-item Likert.a, b,e
[completed by patient & caregiver]
Assess patient’s/family caregiver’s depression and anxiety, α = 0.82.a
Referral will be made [39].
1a.1b HF Home-Care Skills, [40] 9-item Likert.a, b, d, e [completed by
patient & caregiver]
HF home care skills (i.e., if the patient’s legs/ feet are swollen, I contact
MD/nurse), α = 0.80.
1a.1b. Confidence in HF home care, [41] 4-item multiple choice.a, e, f
[completed by patient & caregiver]
Perceived confidence in providing home HF EOLPC, α = 0.87a “How
confident are you in managing your worsening HF at home?”
1a.1b. Preparedness for HF EOLPC Home Care, [42] 1-item Likert.c, e
[completed by patient & caregiver]
Perceived readiness/ability to manage home HF EOLPC.
1b. Caregivers’ quality of life (QoL) SF12v2, [43] 12-item Likert a, c, d, e
[completed by caregiver]
Caregivers’ physical and mental health outcomes.
α = 0.90 to 0.93.
1b. Short-form Zarit Caregiver Burden Interviews, [44, 45] 12-item
Likert.a, c, d, e [completed by caregiver]
Record physical, social, financial, and emotional components of home
caregiving burden, α = 0.89.a, b
Questionnaire Reliabilitya, b, c & Validityd, e, f; aCronbach’s alpha with HF patients; bCronbach’s alpha with healthy population; cReliability reported for adults with
chronic illnesses >0.70; dFactor analysis loadings of subscales >0.35; eEstablished concurrent validity using correlation with other instruments or clinical ratings in
known groups; fPublished norms or ranges
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severe anxiety and depression) will be tracked to com-
pare between groups.
To determine differences between groups on HF
EOLPC decisions, the number of family members and
patients who sign an advance directive form, make a de-
cision, or identify someone who helps them decide on
HF EOLPC options will be tabulated and compared. The
proportion of patients signing an advance directive form
will be used to evaluate the acceptability of EOLPC dis-
cussions. A nurse blinded to group, will adjudicate the
patients’ hospitalizations, ER visits, and causes of death
within the time period to determine if the hospitaliza-
tions and deaths are due to HF. Initial analysis using a
chi-square test (or Fisher’s exact, if event rates are small)
will compare groups on the proportion of subjects who
die or who are rehospitalized due to HF. Kaplan-Meier
method will be used to estimate survival curves (i.e.,
probability of remaining event-free) up to the last
follow-up [47]. Cox proportional hazards regression
model will be used to assess the survival for group dif-
ferences [48]. Subjects’ outcomes will be recorded at the
time of death or last follow-up such as 6 months post-
intervention, whichever comes first.
Data analysis for specific aim 2 (2a & 2b)
Specific aim 2a Aim 2a is to evaluate the quality of
EOLPC of the FamPALcare intervention measured via
(2a.1) patient/family caregiver intervention helpfulness
questionnaire responses; (2a.2) multidisciplinary health-
care professionals’ and rural community leaders’ focus
group research on the FamPALcare outcomes; and (2a.3)
determination of FamPALcare implementation cost using
traditional tabulated cost minimization analysis [49].
For Aim 2a.1, each patient and family member will
rate the helpfulness of each intervention component on
an 11-item Likert-type scale [15] at 3 months following
the FamPALcare intervention. Response options range
from: not helpful (1) to very helpful (5). Sample ques-
tions are: (a) Do you believe the nurse discussions
helped with your HF home care skills? (b) Do you think
the nurse discussions helped you to manage breathless-
ness and prevent rehospitalizations? (c) Did discussion
about EOLPC options help your family decide on a
EOLPC plan? A descriptive analysis will be used to
analyze the family members’ survey responses on the
helpfulness scale.
For Aim 2a.2, multidisciplinary team members and
rural community leaders will complete the 8-item Fam-
PALcare intervention helpfulness scale. Sample helpful-
ness questions are: (a) Do you believe that patients and
their family members received helpful information to
prepare them for their advanced HF? (b) Do you believe
that the FamPALcare intervention contains culturally
sensitive content and examples? Response options range
from: strongly disagree (1) to strongly agree (5). A de-
scriptive analysis will be used to analyze the responses
on the helpfulness scale. The team will discuss topics
where families required reinforcement that arose during
the intervention including the teach-back sessions, to
improve the intervention. These topics will be tabulated
and reported.
Also, multidisciplinary healthcare professional team
members and rural community leaders will be invited to
participate in focus groups to evaluate the EOL interven-
tion and their likelihood to initiate EOLPC coaching ap-
proaches in their own practice. The focus group will be
held in the West Virginia University School of Nursing
conference room, equipped with a telecommunication
system enabling our community team members from
rural areas to participate. The PI will conduct the focus
group discussion with probing questions for clarification
and depth of opinions and the Co-I will facilitate the
focus group discussion and take notes. The focus group
discussion will be audiotaped and data transcriptions
will be summarized with no individual data source dis-
closed. The focus groups of our previous studies were
typically completed in 90 min when data saturation was
achieved (no new topics or information is brought up).
The lead facilitator has experience in focus group re-
search methods and working with HF patients and
caregivers.
Content analysis research methods will be used to
categorize the participants’ focus-group data transcrip-
tions. Content analysis is a method used to identify the
meaning and relationships of words or concepts of spoken
words transcribed into written narrative data [50]. To
ensure the consistency of data interpretation, two re-
searchers will independently categorize the data and then
meet to compare content and resolve any differences in
topic categorization. Data will be summarized in repeating
themes and topics using participants’ own words, which
demonstrates integrity and authentic data [51].
For Aim 2a.3, to determine costs of the FamPALcare
intervention implementation, all charges related to imple-
mentation will be calculated. This includes costs of
personnel time for administering each discussion session,
the materials, home/clinic visit travel, and telephone and
mailing costs. The research costs of data collection and sur-
vey photocopying will be totaled and reported as study
costs. The average intervention implementation cost across
all families will be reported. In terms of potential family
out-of-pocket cost savings, the number of HF related hospi-
talizations and emergency room (ER) visits will be tallied
per patient. The cost of all HF-related hospitalizations and
ER visits 6months prior to the intervention will be com-
pared to 6-month post-intervention using the average cost
of a 20% co-pay for a 4-day hospital stay (the average HF
Piamjariyakul et al. BMC Palliative Care          (2019) 18:119 Page 6 of 9
hospital length of stay) [19] per admission. Patient’s medical
record review (per IRB approval) to determine if the hospi-
talizations/ER/deaths are HF related or not will be adjudi-
cated by the nurse blinded to group assignment.
Specific aim 2b
Specific Aim 2 b is to collect participant recruitment,
enrollment, and retention rates to determine future re-
cruitment strategies and understand reasons for non-
participation to maintain good rates in rural clinical
studies. Descriptive statistics with bar-plots and boxplots
will be used for analysis. Participant recruitment, enroll-
ment, and retention rates will be tabulated and reported.
We will use nurse interventionist observation checklists.
The fidelity of the FamPALcare intervention will be
assessed using trained research nurse observer check-
lists. Fidelity will be rated and addressed to ensure all
EOLPC options are discussed.
Human subject protection and Management of Risks to
subjects
The research team at West Virginia University (WVU)
main campus and at WVU affiliated hospitals and clinics
will conduct subject recruitment. All research staff who
are involved in subject recruitment, medical records
reviews, and data analyses will be trained and will
complete the NIH-approved Human Subjects Protection
Certification through the Collaborative Institutional
Training Initiative (CITI Program). All study participants
(family members and patients) will consent to the study
prior to participating. A HIPAA waiver will be obtained
prior to obtaining a recruitment list from the hospital.
All the research staff will abide by all tenets of WVU’s
confidentiality policies, including privacy-protection
standards for research subjects.
Several procedures are established for protecting
against the risk of breaking confidentiality. Information-
protection procedures specific to data management,
communications, and the electronic environment are
also in place. The questionnaires will be kept in a locked
file cabinet in the research office at all times. Consent
forms are filed separately from the data. Electronic
research-related data will be stored in the designated re-
search network drive under at the university firewall-
protected server, which is backed-up daily.
Data and safety monitoring
All research staff will notify the PI within 24 h if any po-
tential study safety risks arise. The PI then notifies the
IRB within 24 h and notifies National Institute of Nurs-
ing Research (NINR) within 7 days of the investigator
becoming aware of the event. The adverse events will be
systematically monitored and reported. The Safety
Monitoring Committee (SMC) is the monitoring entity
for this RCT. The SMC includes two experts who are in-
dependent of the study protocol. The SMC will review
each potential adverse event (AE) upon its occurrence
(real-time) and bi-annually thereafter. The SMC will
provide direction to conduct interim analyses, stopping
guidelines, and address any ethical issues that may arise
related to palliative care or end-of-life discussions, study
safety and research risks. These recommendations and
actions taken will be reported to the IRB and NINR.
Pitfalls, limitations, and alternatives
Population in West Virginia is predominantly 93%
Caucasian; however, we will make an effort to enroll
other underrepresented minorities into the study. Our
community nurses will continue to engage under-
represented and under-served community leaders and
professionals and provide guidance on identifying and
inviting minority participants. Recruitment from com-
munity health centers will increase the generalizability
of the findings to other Appalachian regions. Although
HF has a high mortality rate, the previous trials with ad-
vanced HF involving family caregivers showed low attri-
tion rate. Most attrition was due to patient death, with
very few caregivers’ withdrawing after patient death out of
appreciation of the continual support from study nurses
for these families [16, 52]. Participation in this study is
likely to increase as program brochures are available in
local churches through lay ministers, faith community
nurses, and in community center announcements. As in
previous studies, nurses, physicians, dieticians, and social
workers who participate in HF patient hospital discharges
or ER visits will refer families to the program. Our study
retention protocols include mailed appointment re-
minders and telephone calls; and preferences for caregiver
involvement with flexible times for coaching sessions.
Discussion
The primary aim of this clinical trial is to compare the
FamPALcare HF patients’ and their family caregivers’
outcomes to standard care control families’ outcomes.
The secondary aim is to assess the implementation of
FamPALcare intervention and the research procedures
to be used in a subsequent large multi-site clinical trial
testing the intervention efficacy. The long-term goal is
to provide home-based EOLPC interventions, including
our new FamPALcare intervention, as an option to ad-
dress the challenge of providing rural EOL care in WV.
The EOLPC options discussed with families are grounded
from evidence-based national clinical guidelines for ad-
vanced HF and on professionals’ recommendations.
The outcomes of this clinical trial will result in new
knowledge on coaching techniques for EOLPC and cul-
turally sensitive approaches to palliative and end-of-life
rural home care. The HF population in WV will benefit
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from a reduction in suffering from the most common se-
vere advanced HF symptoms, selecting their preferred
EOLPC care options, determining their advance direc-
tives, and increasing skills and resources for advanced
HF home care. Clinical findings of this study will be
used to improve the FamPALcare intervention and re-
search protocol for subsequent clinical trials to improve
patients’ and their family caregivers’ home HF end-of-
life and palliative care outcomes. The study will provide
a long-term collaboration with rural community leaders,
and collection of data on the implementation and re-
search procedures for a subsequent large clinical trial of
the FamPALcare intervention. Further, this trial will en-
gage community leaders in the program evaluation
which will promote collaborations for conducting future
translational research. Multidisciplinary students have
opportunity to engage in the research process.
The PI and research team will comply with the NIH
Policy on Dissemination of NIH-Funded Clinical Trial
Information. The information about the clinical trial and
the study results will be updated and made publicly
available, in a timely manner, via ClinicalTrials.gov, a
publicly accessible database operated by the NIH’s Na-
tional Library of Medicine (NLM). Results from the trial
will be submitted within 1 year after the trial’s primary
completion date.
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